Logo image of GRTX

GALERA THERAPEUTICS INC (GRTX) Stock News

NASDAQ:GRTX - Nasdaq - US36338D1081 - Common Stock - Currency: USD

0.145  -0.07 (-32.59%)

After market: 0.1379 -0.01 (-4.9%)

GRTX Latest News, Press Relases and Analysis

News Image
4 months ago - Galera Therapeutics

Galera Therapeutics completes acquisition of Nova Pharmaceuticals

Galera’s development strategy shifts from toxicity reduction to anti-cancer therapeutics, with three trials in patients with highly resistant subsets of...

News Image
9 months ago - BusinessInsider

GRTX Stock Earnings: Galera Therapeutics Reported Results for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Galera Therapeutics (NASDAQ:GRTX) just reported results for the second quarter ...

News Image
9 months ago - InvestorPlace

GRTX Stock Earnings: Galera Therapeutics Reported Results for Q2 2024

Galera Therapeutics just reported results for the second quarter of 2024.

News Image
9 months ago - Galera Therapeutics

Galera Announces Board Approval of Complete Liquidation and Dissolution

Company reports second quarter 2024 financial results...

News Image
9 months ago - Galera Therapeutics

Galera Announces Board Approval of Complete Liquidation and Dissolution

Company reports second quarter 2024 financial results

News Image
a year ago - InvestorPlace

GRTX Stock Earnings: Galera Therapeutics Reported Results for Q1 2024

Galera Therapeutics just reported results for the first quarter of 2024.

News Image
a year ago - InvestorPlace

GRTX Stock Earnings: Galera Therapeutics Beats EPS for Q4 2023

GRTX stock results show that Galera Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

News Image
a year ago - Galera Therapeutics

Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates

Galera's First Quarter 2024 Earnings Release...

News Image
a year ago - Galera Therapeutics

Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates

Company’s evaluation of potential strategic alternatives progresses with goal to maximize stockholder value

News Image
a year ago - Galera Therapeutics

Galera Adopts Limited Duration Stockholder Rights Agreement

MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of...

News Image
a year ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

It's time to start ofd the trading week with a look at the biggest pre-market stock movers traders need to watch on Monday morning!

Mentions: MLEC OLB CSLR SPCB ...

News Image
a year ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

It's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Wednesday!

Mentions: INVO VNDA VIAO CLNN ...

News Image
a year ago - Galera Therapeutics

Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates

Company continues to evaluate strategic options to maximize shareholder value...

News Image
a year ago - Galera Therapeutics

Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates

Company continues to evaluate strategic options to maximize shareholder value

News Image
a year ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

The biggest pre-market stock movers for Wednesday are ready to go as we break down all of the latest news moving shares today!

Mentions: NVNI ZJYL ICCT CVKD ...